Quick Answer
Opus Genetics, Inc. reported Stockholders Equity of $15.35 million for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +128.3% in Stockholders Equity from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $28.03 million | Q2 2014: $30.31 million | Q3 2014: $28.60 million | Q1 2015: $23.38 million | Q2 2015: $21.43 million | Q3 2015: $17.71 million | Q1 2016: $17.21 million | Q2 2016: $15.81 million | Q3 2016: $17.24 million | Q1 2017: $1.13 million | Q2 2017: $15.90 million | Q3 2017: $15.12 million | Q1 2018: $14.97 million | Q2 2018: $11.42 million | Q3 2018: $6.41 million | Q1 2019: $15.94 million | Q2 2019: $13.62 million | Q3 2019: $11.76 million | Q1 2020: -$8.46 million | Q2 2020: -$8.78 million | Q3 2020: -$9.41 million | Q1 2021: $9.82 million | Q2 2021: $22.55 million | Q3 2021: $20.57 million | Q1 2022: $17.27 million | Q2 2022: $14.60 million | Q3 2022: $11.88 million | Q1 2023: $41.25 million | Q2 2023: $37.70 million | Q3 2023: $50.28 million | Q1 2024: $46.06 million | Q2 2024: $40.64 million | Q3 2024: $34.30 million | Q1 2025: $5.07 million | Q2 2025: $17.47 million | Q3 2025: $5.97 million.
- Over the full 17 years of available data (2009 to 2025), Opus Genetics, Inc.'s Stockholders Equity has grown by 213.1%.
- Historical annual values: Fiscal year 2025: $15.35 million | Fiscal year 2024: $6.72 million | Fiscal year 2023: $49.91 million | Fiscal year 2022: $46.24 million | Fiscal year 2021: $22.22 million | Fiscal year 2020: -$13.47 million | Fiscal year 2019: -$7.56 million | Fiscal year 2018: -$1.70 million | Fiscal year 2017: $16.77 million | Fiscal year 2016: $17.06 million | Fiscal year 2015: $18.78 million | Fiscal year 2014: $26.58 million | Fiscal year 2013: $12.63 million | Fiscal year 2012: $9.53 million | Fiscal year 2011: $10.71 million | Fiscal year 2010: $10.40 million | Fiscal year 2009: $4.90 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: